"The US Food and Drug Administration (FDA) has approved an expanded indication for onabotulinum toxin A (Botox, Actavis) for the treatment of adults with upper limb spasticity, according to a company news release.
The expanded i"...
(Generic versions may still be available.)
TONOCARD*(Tocainide HCl) is a primary amine analog of lidocaine with antiarrhythmic properties useful in the treatment of ventricular arrhythmias. The chemical name for tocainide hydrochloride is 2-amino-N-(2,6-dimethylphenyl) propanamide hydrochloride. Its empirical formula is C11H16N2O † HCl, with a molecular weight of 228.72.
Tocainide hydrochloride is a white crystalline powder with a bitter taste and is freely soluble in water. It is supplied as 400 mg and 600 mg tablets for oral administration. Each tablet contains the following inactive ingredients: hydroxypropyl methylcellulose, iron oxide, magnesium stearate, methylcellulose, polyethylene glycol, and titanium dioxide.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Tonocard Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.